Physician profile
Mark S Brazinski
NPI 1003869371
$1,125.76
in general payments reported to CMS, 2019-2025
21 companies · $37.54 in 2025
The $37.54 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $184 · 2021: $51.36 · 2022: $53.12 · 2023: $41.19 · 2024: $121 · 2025: $37.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $525.05 | 2019-2020 | |
| Medical Device Business Services, INC. | $120.00 | 2020 | |
| Bioventus LLC | $49.06 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $46.33 | 2019 | |
| Abbott Laboratories | $40.82 | 2022-2025 | Eterna |
| Depuy Synthes Sales INC. | $37.92 | 2021-2023 | Viper |
| Smith+Nephew, INC. | $34.41 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System |
| Scilex Pharmaceuticals INC. | $32.81 | 2024 | |
| Baxter Healthcare | $30.71 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $28.02 | 2024 | |
| Sanofi-Aventis U.S. LLC | $21.28 | 2019 | |
| Averitas Pharma INC. | $20.89 | 2024 | Qutenza |
| Radius Health, INC. | $20.67 | 2021 | |
| Collegium Pharmaceutical, INC. | $20.44 | 2024 | Xtampza |
| Nevro Corp. | $20.31 | 2023 | Senza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curasan, INC. | $18.94 | 2019 | |
| Biodelivery Sciences International, INC. | $13.65 | 2021 | |
| Ethicon US, LLC | $13.42 | 2022 | |
| Pfizer INC. | $12.45 | 2020 | |
| Baudax Bio INC. | $11.95 | 2020 | |
| Kinex Medical Company LLC | $6.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Brazinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.